The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancer

Radiotherapy and Oncology

Volumn 91, Issue 1, 2009, Pages 49-53

  Diepenmaat, Lindy A ^a   Sangen, Maurice J C van der ^b   Poll Franse, Lonneke V van de ^c,d   Beek, Mike W P M van ^e   Berlo, Charles L H van ^f   Luiten, Ernest J T ^g   Nieuwenhuijzen, Grard A P ^b   Voogd, Adri C ^h  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c Eindhoven Cancer Registry   (Netherlands)

^d TILBURG UNIVERSITY   (Netherlands)

^e Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

^f VIECURI MEDICAL CENTER   (Netherlands)

^g ST ANNA HOSPITAL   (Netherlands)

^h MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Breast carcinoma; Lobular type; Local control; Mastectomy; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROL GROUP; DISEASE FREE SURVIVAL; FOLLOW UP; GENERAL HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; NETHERLANDS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 62549137407     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.09.012     Document Type: Article

References (22)

1. The world Health Organization histological typing of breast tumors-Second ed. The World Organization. Am J Clin Pathol 1982;78:806-816.
2. Fisher E.R., Gregorio R.M., Fisher B., Redmond C., Vellios F., and Sommers S.C. The pathology of invasive breast cancer. A syllabus derived from findings of the national surgical adjuvant breast project (protocol no4). Cancer 36 (1975) 1-85
3. Wellings S.R., Jensen H.M., and Marcum R.G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55 (1975) 231-273
4. Martinez V., and Azzopardi J.G. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology 3 (1979) 467-488
5. Sastre-Garau X., Jouve M., Asselain B., et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 77 (1996) 113-120
6. Yeatman T.J., Cantor A.B., Smith T.J., et al. Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222 (1995) 549-559 discussion 559-61
7. Silverstein M.J., Lewinsky B.S., Waisman J.R., et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?. Cancer 73 (1994) 1673-1677
8. Moore M.M., Borossa G., Imbrie J.Z., Fechner R.E., Harvey J.A., Slingluff Jr. C.L., et al. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg 231 (2000) 877-882
9. Peiro G., Bornstein B.A., Connolly J.L., et al. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59 (2000) 49-54
10. Holland P.A., Shah A., Howell A., Baildam A.D., and Bundred N.J. Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg 82 (1995) 1364-1366
11. Warneke J., Berger R., Johnson C., Stea D., and Villar H. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. Am J Surg 172 (1996) 496-500
12. Chung M.A., Cole B., Wanebo H.J., Bland K.I., and Chang H.R. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol 4 (1997) 545-550
13. Singletary S.E., Patel-Parekh L., and Bland K.I. Treatment trends in early-stage invasive lobular carcinoma: a report from the national cancer data base. Ann Surg 242 (2005) 281-289
14. van den Broek N., van der Sangen M.J., van de Poll-Franse L.V., van Beek M.W., Nieuwenhuijzen G.A., and Voogd A.C. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat 105 (2007) 63-68
15. Voogd A.C., Nielsen M., Peterse J.L., et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19 (2001) 1688-1697
16. Bontenbal M., Nortier J.W., Beex L.V., Bakker P., Hupperets P.S., Nooij M.A., et al. Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for medical oncology. Ned Tijdschr Geneeskd 144 (2000) 984-989
17. Goldhirsch A., Glick J.H., Gelber R.D., and Senn H.J. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90 (1998) 1601-1608
18. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: international consensus panel on the treatment of primary breast cancer. Seventh international conference on adjuvant therapy of primary breast cancer. J Clin Oncol 2001;19:3817-3827.
19. du Toit R.S., Locker A.P., Ellis I.O., et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 17 (1991) 251-257
20. Hussien M., Lioe T.F., Finnegan J., and Spence R.A. Surgical treatment for invasive lobular carcinoma of the breast. Breast 12 (2003) 23-35
21. Overgaard M., Nielsen H.M., and Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82 (2007) 247-253
22. Hooning M.J., Aleman B.M., van Rosmalen A.J., et al. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys 64 (2006) 1081-1091